The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels. The latest salvo in the …
The article Insurers Balk at High Cost of Specialty Drug appeared first on Insurance Journal.
more
{ 0 comments... » Insurers Balk at High Cost of Specialty Drug read them below or add one }
Post a Comment